Form 8-K - Current report:
SEC Accession No. 0001193125-25-292015
Filing Date
2025-11-24
Accepted
2025-11-24 07:24:48
Documents
16
Period of Report
2025-11-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d23843d8k.htm   iXBRL 8-K 33489
2 EX-1.1 d23843dex11.htm EX-1.1 249409
3 EX-5.1 d23843dex51.htm EX-5.1 58201
8 GRAPHIC g23843g1120224650146.jpg GRAPHIC 3119
  Complete submission text file 0001193125-25-292015.txt   590602

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cnta-20251124.xsd EX-101.SCH 3867
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnta-20251124_def.xml EX-101.DEF 14485
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnta-20251124_lab.xml EX-101.LAB 24177
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnta-20251124_pre.xml EX-101.PRE 15583
19 EXTRACTED XBRL INSTANCE DOCUMENT d23843d8k_htm.xml XML 6423
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40445 | Film No.: 251509573
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)